Hyperthermic intraperitoneal chemotherapy in colorectal cancer

202417 citationsJournal Articlegold Open Access

Authors

Oliver M. Fisher · Sutherland Hospital

Chris Brown · Respiratory Clinical Trials

Jesús Esquivel · Calvert Memorial Hospital

Stein Gunnar Larsen · Oslo University Hospital

Winston Liauw · Sutherland Hospital

Nayef Alzahrani · King Abdulaziz Medical City

David L. Morris ·

Abstract

Oxaliplatin-based HIPEC provided better outcomes compared to mitomycin-based HIPEC. High-dose mitomycin-HIPEC was similar to oxaliplatin-HIPEC. The 90-day mortality difference favours the oxaliplatin-HIPEC group. A trend for dose-response between low- and high-dose HIPEC was reported.

Topics & Keywords

Intraperitoneal and Appendiceal Malignancies Hepatocellular Carcinoma Treatment and Prognosis Amoebic Infections and Treatments

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: BJS Open

Volume 8, Issue 3

DOI: 10.1093/bjsopen/zrae017

Field-Weighted Citation Impact: 9.83